Eastman Kodak Expands KODAK Pharmaceuticals Portfolio With U.S.-Made 0.9% Normal Saline And Launches Online Store For Life Science Customers

Eastman Kodak Company today announced the expansion of its KODAK PHARMACEUTICALS portfolio with the addition of KODAK® Normal Saline, 0.9%. The company also introduced a new U.S.-based online store designed to simplify purchasing for pharmaceutical, biotech, and life science customers.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261028327829/en/

This product addition builds on Kodak’s growing portfolio of sterile, ready-to-use buffers and reagents manufactured in its U.S.-based, FDA-registered cGMP facility.

Building a Core Portfolio of Essential Reagents

KODAK Normal Saline, 0.9% expands Kodak’s portfolio into sterile reagents for laboratory and bioprocessing workflows. Manufactured and aseptically filled in the United States, the isotonic solution is fully traceable and USP-compliant where applicable. It supports Kodak’s strategy to provide customers in regulated environments with consistent quality, transparent sourcing and a more reliable domestic supply.